NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
Healthcare Analytics Platform technology focused on delivering clinical grade actionable data in remote settings
Digital Health sales and marketing company formed in partnership with iMPak Health, a wholly owned subsidiary of US hospital group, Meridian Health, NJ
Non-invasive glucose monitoring wearable device for the medical and consumer wellness market
‘EKG for the gut’ - Wearable patch technology for diagnosis and monitoring of functional gastric disorders
Circulating Tumor Cell identification, selection and analysis for disease monitoring and personalised therapeutic prescribing
The partnership with Breakout Labs provides NetScientific and its investors with access to some of the most revolutionary new technologies coming out of Silicon Valley and beyond.